BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33718220)

  • 21. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
    Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
    EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling.
    Wang X; Shi A; Liu J; Kong W; Huang Y; Xue W; Yang F; Huang J
    Cancer Cell Int; 2024 Apr; 24(1):147. PubMed ID: 38658931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma.
    Tan HS; Jiang WH; He Y; Wang DS; Wu ZJ; Wu DS; Gao L; Bao Y; Shi JZ; Liu B; Ma LJ; Wang LH
    Oncotarget; 2017 Sep; 8(44):76189-76203. PubMed ID: 29100303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
    Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
    Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2.
    An J; Yang J; Yao Y; Lu K; Zhao Z; Yu M; Zhu Y
    Oncol Lett; 2021 Apr; 21(4):293. PubMed ID: 33732369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin-1 expression.
    Lin ZZ; Ming DS; Chen YB; Zhang JM; Chen HH; Jiang JJ; Zhang ZS
    Oncol Lett; 2019 Jun; 17(6):4907-4913. PubMed ID: 31186699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of miR-155 in clear-cell renal cell carcinoma and its oncogenic effect through targeting FOXO3a.
    Ji H; Tian D; Zhang B; Zhang Y; Yan D; Wu S
    Exp Ther Med; 2017 May; 13(5):2286-2292. PubMed ID: 28565840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma.
    Jin P; Wang J; Liu Y
    Exp Ther Med; 2017 Mar; 13(3):1137-1142. PubMed ID: 28450954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
    Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
    Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
    Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.